Table 1.
Group | Survivors
|
||||
---|---|---|---|---|---|
Immunization
|
After immunization | After challenge*
|
|||
Virus | Dose, pfu | 1 × 105pfu | 5 × 106pfu | ||
A | A/delNS1 | 1.0 × 106 | 9/9 | 5/5 | 4/4 |
B | 3.3 × 104 | 5/5 | 0/5 | ND | |
C | A/NS1-99 | 1.0 × 106 | 8/10 | 5/5 | 3/3 |
D | 3.3 × 104 | 9/10 | 3/5 | 4/4 | |
E | A/PR8 | 2.0 × 103 | 1/5 | ND | 1/1 |
F | PBS | 0 | 6/6 | 0/6 | ND |
Mice were challenged with 1 × 105 pfu (100 LD50) or with 5 × 106 pfu (5,000 LD50) influenza A/PR8 virus 4 wk after immunization. ND, not determined.